Edition:
India

Laboratory Corporation of America Holdings (LH.N)

LH.N on New York Stock Exchange

155.77USD
1:44am IST
Change (% chg)

$-0.49 (-0.31%)
Prev Close
$156.26
Open
$156.67
Day's High
$157.78
Day's Low
$155.72
Volume
41,597
Avg. Vol
168,377
52-wk High
$164.20
52-wk Low
$126.44

Chart for

About

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $15,533.50
Shares Outstanding(Mil.): 102.43
Dividend: --
Yield (%): --

Financials

BRIEF-Labcorp announces new expanded use for PD-L1 test with Bristol-Myers Squibb's Opdivo

Nov 15 Laboratory Corporation Of America Holdings

15 Nov 2017

BRIEF-Labcorp - Co,‍ Capital Health announced that they have entered into a laboratory partnership​

* Labcorp - Co,‍ Capital Health announced that they have entered into a laboratory partnership​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

01 Nov 2017

UPDATE 2-Diagnostics power LabCorp's beat-and-raise quarter

Oct 25 Laboratory Corp of America Holdings' profit topped analysts' estimates and the company raised its full-year revenue growth forecast on Wednesday, expecting growth from its diagnostics business.

25 Oct 2017

LabCorp posts marginal rise in quarterly profit

Oct 25 Laboratory Corp of America Holdings reported a marginal rise in quarterly profit, helped by higher demand for its diagnostic services, even as costs rose.

25 Oct 2017

BRIEF-LabCorp objects to proposed PAMA 2018 Medicare payment rates for clinical laboratory tests

Sept 25 Laboratory Corporation Of America Holdings

25 Sep 2017

BRIEF-Luminex Corp - Labcorp agrees to extend commitment to Luminex Cystic Fibrosis

Sept 12 Laboratory Corporation Of America Holdings

12 Sep 2017

BRIEF-Interpace Diagnostics announces renewal and extension of LabCorp national agreement

* Interpace Diagnostics announces renewal and extension of LabCorp national agreement

28 Aug 2017

BRIEF-Chromadex sells its analytical testing business to LabCorp

* Chromadex sells its analytical testing business to LabCorp, to accelerate the expansion of Nicotinamide Riboside and its other patented ingredient technologies

23 Aug 2017

BRIEF-LabCorp announces proposed sale of senior notes

Aug 15 Laboratory Corporation Of America Holdings:

15 Aug 2017

BRIEF-Labcorp files for potential mixed shelf offering ‍​

* Files for potential mixed shelf offering; size not disclosed - sec filing‍​ Source text for Eikon: Further company coverage:

15 Aug 2017

Earnings vs. Estimates